During the past decade, Spitalul Clinic Judetean de Urgenta Cluj Napoca conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 16 clinical trials were completed, i.e. on average, 55.2% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 11 clinical trials were completed. i.e. 84.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Spitalul Clinic Judetean de Urgenta Cluj Napoca" #1 sponsor was "Shire" with 6 trials, followed by "Pfizer" with 4 trials sponsored, "Sunovion" with 4 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Spitalul Clinic Judetean de Urgenta Cluj Napoca" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "B. Braun Melsungen AG" with 1 trials as a collaborator, "European Society of Anaesthesiology and Intensive Care" with 1 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Spitalul Clinic Judetean de Urgenta Cluj Napoca" are "Ulcerative Colitis" (6 trials), "Systemic Lupus Erythematosus" (5 trials), "Crohn's Disease" (4 trials), "Bipolar Depression" (3 trials) and "Epilepsy" (2 trials). Many other conditions were trialed in "Spitalul Clinic Judetean de Urgenta Cluj Napoca" in a lesser frequency.

Most popular intervention types in "Spitalul Clinic Judetean de Urgenta Cluj Napoca" are "Drug" (41 trials), "Other" (7 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Etrasimod" (4 trials), "Ontamalimab" (4 trials), "Zonisamide" (2 trials) and "lurasidone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Spitalul Clinic Judetean de Urgenta Cluj Napoca" are 40 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Spitalul Clinic Judetean de Urgenta Cluj Napoca". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Spitalul Clinic Judetean de Urgenta Cluj Napoca, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Spitalul Clinic Judetean de Urgenta Cluj Napoca, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".